Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AAV1/SERCA2a Gene Transfer in Heart Failure Patients with LVAD
NCT00534703Phase 2Terminated
- Sponsor
- Imperial College London
- Start
- Jul 2014
- Primary completion
- Sep 2015
- Modality
- Gene Editing, Gene Silencing, Viral Vectors
- Countries
- 1
01
Overview
A Phase 2 trial of AAV1/SERCA2a in chronic heart failure (CHF), sponsored by Imperial College London. Started Jul 2014; status: terminated.
02
Drugs
AAV1/SERCA2a
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT00534703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00534703.